News

Rigel Pharmaceuticals Set to Share Q3 2024 Insights Soon

Rigel Pharmaceuticals Set to Share Q3 2024 Insights Soon

Rigel Pharmaceuticals Announces Upcoming Conference Call

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is poised to share its financial results for the third quarter of 2024 after the market closes soon. The company's management has scheduled a live conference call to discuss a detailed business update and the financial results with all interested parties.

Details of the Financial Results Call

The announcement specifies that the financial results will be unveiled after market close. Following this, senior management from Rigel will host a conference call to address the results, providing insights into the company's performance and strategic direction going forward.

How to Participate in the Conference Call

Interested participants can join the live conference call by dialing 877-407-3088 for domestic calls or 201-389-0927 for international access. Additionally, the conference call will be accompanied by a slideshow presentation that will be accessible live. For those unable to participate at the moment, an archived version will be available for replay from the company's website for 90 days after the event.

About Rigel Pharmaceuticals

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) stands out as a biotechnology company committed to the discovery, development, and delivery of innovative therapies aimed at significantly improving the lives of patients facing hematologic disorders and cancer. Established in 1996 and headquartered in South San Francisco, California, Rigel continues to innovate in the healthcare sector.

Exploring Rigel's Pipeline and Marketed Products

Investors and stakeholders interested in the company's full range of marketed products and its pipeline of potential therapies can visit the official website for in-depth information. Rigel keeps an active commitment to developing treatments that can alleviate the burdens of those suffering from complex medical conditions.

Contact Information for Investors and Media

For those seeking additional details, Rigel has made it easy to reach out. The company's investor relations team can be contacted directly at 650.624.1232. This is particularly beneficial for investors desiring further clarity on Rigel's future direction.

Media Inquiries and More

Members of the media can get in touch with David Rosen at Argot Partners through the dedicated number 646.461.6387. He is available to provide media-focused insights pertaining to Rigel Pharmaceuticals.

Frequently Asked Questions

What will Rigel Pharmaceuticals announce on the call?

Rigel will share its financial results for Q3 2024 and provide an update on business activities.

How can I attend the Rigel conference call?

You can join the call by dialing 877-407-3088 for domestic access or 201-389-0927 internationally.

Will the conference call be available for replay?

Yes, the conference call will be archived and available for replay for 90 days following the live event.

Where can I find more information about Rigel’s products?

Detailed information about Rigel's marketed products and pipeline can be found on their official website.

Who can I contact for investor inquiries?

You can reach Rigel's investor relations team at 650.624.1232 for inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ballard Power Eyes Profitability and Growth by 2028

Updated Category News Views 2

Ballard's Bold Vision for the Future In the sweaty scramble of this hydrogen race, Ballard Power Systems flung their ambition squarely into the ring. Their eyes are set on Adjusted EBITDA profitability by the end of 2027 with a full-year stretch into 2028. It's not just hope they're peddling; they've got a plan, folks! Unpacking the Numbers: Revenue and Strategy...

Continue Reading
Sony's IMX742: Revolutionizing Endoscopic Imaging

Updated Category News Views 7

Sony's Bold Move into Medical Tech You wouldn't expect a company like Sony to make waves in the medical field, but there they go again, shaking things up with their latest announcement. Lurking past the shiny consumer electronics, they've got the IMX742, a sensor designed for single-use endoscopes. A humble 1 mm square powerhouse, boasting about 0.51 megapixels of digital...

Continue Reading
Brewer Foundation Shatters Records with IPPF Entries

Updated Category News Views 3

A New Milestone in Global Debate The Brewer Foundation is making waves across the debate world, claiming a groundbreaking enrollment for their 2026-27 International Public Policy Forum (IPPF). Let’s talk numbers for a moment—506 teams from a whopping 62 different countries, not to mention new entries from places like France, Mexico, Curaçao, and Russia, all eager to...

Continue Reading
Chemours Investors Face Crucial Class Action Deadline

Updated Category News Views 7

High Stakes for Chemours Shareholders Well, this isn’t your run-of-the-mill shareholder grumble. We're staring down an 18.63% plunge in Chemours’ stock—plenty to raise the eyebrows of anyone keeping tabs on this chemical giant. For those who snatched up Chemours shares between February 20 and August 4, 2026, the revelations about potential misstatements concerning...

Continue Reading
Rentvine Unleashes AI Innovations in Property Management

Updated Category News Views 5

Rentvine's Leap in AI Technology Right off the bat, let's give these guys some due credit. Rentvine, located in Bonita Springs, is tearing through the property management software scene like a train on rocket fuel. They just rolled out a suite of AI tools that's shaking up the single-family rentals management industry. During NARPM National in Las Vegas, they showcased...

Continue Reading
45% of Firms Lack AI Integration Leadership

Updated Category News Views 3

Unclaimed Territory in the AI Era Mid-market businesses have leapt onto the AI bandwagon with wild enthusiasm, yet they're stumbling in the dark when it comes to making it work. The latest findings from Lever Talent, a talent evolution firm, spill the beans that about 45% of these outfits lack a designated maestro to lead the AI-human orchestra. Without a clear conductor,...

Continue Reading
Side Bolsters Art Division with Roboto Acquisition

Updated Category News Views 8

Breaking Into China's Game Art Market The gaming industry's latest buzz centers around Side's acquisition of Roboto Entertainment, a boutique art studio known for crafting immersive game environments. This isn't just another headline grab—this move puts Side smack dab in the heart of China's burgeoning game market with a fresh Chengdu base. Expansion With Strategic...

Continue Reading
Graybar's Integrity Shines: Forbes Honors Trust Again

Updated Category News Views 0

Trust Is Graybar's Secret Sauce Graybar's been hauling the trust trophy back home from Forbes for the second year straight. This ain't just another fleeting accolade—the kind you hang on the office wall without meaning it. What's brewing here is more profound, nestled in the heart of St. Louis and bubbling through its logistics veins. Being named one of Forbes' 2027...

Continue Reading
ManpowerGroup to Feature at J.P. Morgan Conference

Updated Category News Views 5

ManpowerGroup Heads to the Big Apple ManpowerGroup's top brass are packing their bags for New York City, heading to the J.P. Morgan Ultimate Services Investor Conference. Now, this isn’t just another cookie-cutter investor meet-up. Jack McGinnis, the CFO, and Becky Frankiewicz, the President and Chief Strategy Officer, are slated to have a fireside chat on November 17,...

Continue Reading
Elanco's Strategic Shift: Jamie Preston Takes the Helm

Updated Category News Views 6

Elanco's Bold HR Transition: A New Leader Steps Up Well, here's a shake-up that might just turn a few heads in the corporate world. Elanco Animal Health, the outfit with the ticker NYSE:ELAN that many have their eyes on, is shuffling its HR deck, bringing in Jamie Preston from Eli Lilly to take charge as the new Chief People Officer. Mark November 3rd on your calendars;...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: Replimune Group Faces Class Action Deadline

Updated Category News Views 103

Replimune Group, Inc. Shareholder Class Action Notification The Gross Law Firm wishes to inform investors of Replimune Group, Inc. (NASDAQ: REPL) about an important class action lawsuit that is currently in progress. This notice serves as a prompt to shareholders who purchased shares during the specified class period to engage with the firm regarding possible lead...

Continue Reading
First Commerce Bancorp Delivers Strong Performance Metrics

Updated Category News Views 125

Company Overview First Commerce Bancorp, Inc. (CMRB), parent company of First Commerce Bank, has recently announced impressive financial results for the second quarter and year-to-date periods ending June 30, 2025. This performance underscores the bank's strategic initiatives and growth trajectory in a competitive financial landscape. Financial Performance Highlights...

Continue Reading
Silo Pharma Achieves Patent Success and Stock Surge

Updated Category News Views 195

Silo Pharma Achieves New Patent Milestone Silo Pharma Inc. recently experienced a significant boost in its stock prices following an important announcement regarding its lead product, SPC-15, a treatment designed for PTSD. This surge comes on the heels of the company securing a new U.S. patent for its innovative approach to treating post-traumatic stress disorder....

Continue Reading
Discovering Willows at Brookfield: A New Luxury Townhome Community

Updated Category News Views 170

Welcome to Willows at Brookfield Willows at Brookfield, a newly unveiled luxury townhome community, is making waves in the housing market. Known for its stunning architectural designs and modern conveniences, this community is set to become a sought-after location for homebuyers. Nestled near beautiful landscapes and outdoor recreational spots, this neighborhood features...

Continue Reading
Exploring New Depths: VR Resources' Advances in Copper Exploration

Updated Category News Views 219

Innovative Geophysical Surveys Completed at Empire and Silverback Projects VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCBB: VRRCF) has achieved a significant milestone with the completion of two advanced Direct Current Induced Polarization (DCIP) geophysical surveys at their Empire and Silverback projects located in Northwestern Ontario. As these state-of-the-art surveys...

Continue Reading